GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Scaled Net Operating Assets

Oxford BioDynamics (LSE:OBD) Scaled Net Operating Assets : 0.51 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Oxford BioDynamics's operating assets for the quarter that ended in Sep. 2023 was £10.88 Mil. Oxford BioDynamics's operating liabilities for the quarter that ended in Sep. 2023 was £3.63 Mil. Oxford BioDynamics's Total Assets for the quarter that ended in Mar. 2023 was £14.28 Mil. Therefore, Oxford BioDynamics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was 0.51.


Oxford BioDynamics Scaled Net Operating Assets Historical Data

The historical data trend for Oxford BioDynamics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Scaled Net Operating Assets Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.12 0.60 0.50 0.64

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.55 0.53 0.78 0.51

Competitive Comparison of Oxford BioDynamics's Scaled Net Operating Assets

For the Biotechnology subindustry, Oxford BioDynamics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Scaled Net Operating Assets falls into.



Oxford BioDynamics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Oxford BioDynamics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Sep. 2023 )
=(Operating Assets (A: Sep. 2023 )-Operating Liabilities (A: Sep. 2023 ))/Total Assets (A: Sep. 2022 )
=(10.877-3.633)/11.344
=0.64

where

Operating Assets(A: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=16.127 - 5.25
=10.877

Operating Liabilities(A: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.072 - 5.621 - 0.818
=3.633

Oxford BioDynamics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2023 )
=(Operating Assets (Q: Sep. 2023 )-Operating Liabilities (Q: Sep. 2023 ))/Total Assets (Q: Mar. 2023 )
=(10.877-3.633)/14.282
=0.51

where

Operating Assets(Q: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=16.127 - 5.25
=10.877

Operating Liabilities(Q: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.072 - 5.621 - 0.818
=3.633

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (LSE:OBD) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines